Evidence map›Paper›PMID 25574029›Full record

ArticleHuman molecular genetics2015

MATR3 disruption in human and mouse associated with bicuspid aortic valve, aortic coarctation and patent ductus arteriosus.

Fabiola Quintero-Rivera, Qiongchao J Xi, Kim M Keppler-Noreuil, Ji Hyun Lee, Anne W Higgins, Raymond M Anchan, Amy E Roberts, Ihn Sik Seong, Xueping Fan, Kasper Lage and 12 more

Open access · hybridAbstract read
In one paragraph

Article in Human molecular genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 103 citations in OpenAlex.

  1. Endothelial Matrin-3 Limits Cellular Senescence and Lipid Dysregulation to Protect Against Murine Atherosclerosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Article
  4. Phenotypic subtypes of Xia-Gibbs syndrome: a latent class analysis.European journal of human genetics : EJHG · 2025
    Review
  5. Review
  6. Article
  7. Molecular syndromology · 2024
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 13 institutions in 2 countries.

Fabiola Quintero-RiveraMolecular Neurogenetics Unit and Center for Human Genetic Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Qiongchao J XiDivision of Genetics, Department of Medicine.
Kim M Keppler-NoreuilDivision of Medical Genetics, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Ji Hyun LeeMolecular Neurogenetics Unit and Center for Human Genetic Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Anne W HigginsDepartment of Obstetrics, Gynecology and Reproductive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Raymond M AnchanDivision of Genetics, Department of Medicine, Department of Obstetrics, Gynecology and Reproductive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Amy E RobertsDepartment of Cardiology, Division of Genetics, Department of Medicine, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
Ihn Sik SeongMolecular Neurogenetics Unit and Center for Human Genetic Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Xueping FanRenal Section, Department of Medicine, Boston University Medical Center, Boston, MA, USA.
Kasper LagePediatric Surgical Research Laboratories, Department of Surgery, Massachusetts General Hospital for Children and Harvard Medical School, Boston, MA, USA.
Lily Y LuDivision of Genetics, Department of Medicine.
Joanna TaoDivision of Genetics, Department of Medicine.
Xuchen HuDivision of Genetics, Department of Medicine.
Ronald BerezneyDepartment of Biological Sciences, University at Buffalo, Buffalo, NY, USA.
Bruce D GelbMindich Child Health and Development Institute, Departments of Pediatrics and Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, NY, USA.
Anna KampDepartments of Pediatrics and Pathology, University of Chicago, Chicago, IL, USA and.
Ivan P MoskowitzDepartments of Pediatrics and Pathology, University of Chicago, Chicago, IL, USA and.
Ronald V LacroDepartment of Cardiology.
Weining LuRenal Section, Department of Medicine, Boston University Medical Center, Boston, MA, USA.
Cynthia C MortonDepartment of Obstetrics, Gynecology and Reproductive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
James F GusellaMolecular Neurogenetics Unit and Center for Human Genetic Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, gusella@helix.mgh.harvard.edu maas@genetics.med.harvard.edu.
Richard L MaasDivision of Genetics, Department of Medicine, gusella@helix.mgh.harvard.edu maas@genetics.med.harvard.edu.
Pediatrics and Genetics · USCenter for Human Genetics · USHarvard University · USInstitute of Cardiology · PLUniversity of Chicago · USBoston Medical Center · USBrigham and Women's Hospital · USChild Health and Development Institute · USMassachusetts General Hospital · USUniversity at Buffalo, State University of New York · USUniversity Medical Center · USUniversity of California, Los Angeles · USUniversity of Iowa Hospitals and Clinics · US

Funding

UCLA-Caltech Medical Scientist Training ProgramT32GM008042 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AJIJOLA, OLUJIMI A, DAWSON, DAVID WAYNE · 1985 to 2023
$29.9M
RAPID GENE DISCOVERYP01GM061354 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI MORTON, CYNTHIA CASSON · 2001 to 2019
$24.3M
Molecular studies of Noonan syndrome and related disordersR01HL071207 · NHLBI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI GELB, BRUCE D · 2002 to 2016
$5.9M
Discovering Human Birth Defect Genes from Chromosomal RearrangementsR01HD060050 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · PI MAAS, RICHARD L · 2009 to 2013
$2.0M
NHLBI NIH HHS R01HL071207NICHD NIH HHS R01HD060050NIGMS NIH HHS P01 GM061354NIGMS NIH HHS P01GM061354NIGMS NIH HHS T32 GM008042
6 · The paper itself

Abstract

Cardiac left ventricular outflow tract (LVOT) defects represent a common but heterogeneous subset of congenital heart disease for which gene identification has been difficult. We describe a 46,XY,t(1;5)(p36.11;q31.2)dn translocation carrier with pervasive developmental delay who also exhibited LVOT defects, including bicuspid aortic valve (BAV), coarctation of the aorta (CoA) and patent ductus arteriosus (PDA). The 1p breakpoint disrupts the 5' UTR of AHDC1, which encodes AT-hook DNA-binding motif containing-1 protein, and AHDC1-truncating mutations have recently been described in a syndrome that includes developmental delay, but not congenital heart disease [Xia, F., Bainbridge, M.N., Tan, T.Y., Wangler, M.F., Scheuerle, A.E., Zackai, E.H., Harr, M.H., Sutton, V.R., Nalam, R.L., Zhu, W. et al. (2014) De Novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea. Am. J. Hum. Genet., 94, 784-789]. On the other hand, the 5q translocation breakpoint disrupts the 3' UTR of MATR3, which encodes the nuclear matrix protein Matrin 3, and mouse Matr3 is strongly expressed in neural crest, developing heart and great vessels, whereas Ahdc1 is not. To further establish MATR3 3' UTR disruption as the cause of the proband's LVOT defects, we prepared a mouse Matr3(Gt-ex13) gene trap allele that disrupted the 3' portion of the gene. Matr3(Gt-ex13) homozygotes are early embryo lethal, but Matr3(Gt-ex13) heterozygotes exhibit incompletely penetrant BAV, CoA and PDA phenotypes similar to those in the human proband, as well as ventricular septal defect (VSD) and double-outlet right ventricle (DORV). Both the human MATR3 translocation breakpoint and the mouse Matr3(Gt-ex13) gene trap insertion disturb the polyadenylation of MATR3 transcripts and alter Matrin 3 protein expression, quantitatively or qualitatively. Thus, subtle perturbations in Matrin 3 expression appear to cause similar LVOT defects in human and mouse.

Indexed as

AdolescentAnimalsAortic CoarctationAortic ValveBicuspid Aortic Valve DiseaseChild, PreschoolDNA-Binding ProteinsDuctus Arteriosus, PatentFemaleGene SilencingHeart Valve DiseasesHeart VentriclesHumansInfant, NewbornMaleMiceAHDC1 protein, humanDNA-Binding ProteinsMATR3 protein, humanmatrin-3 protein, mouseNuclear Matrix-Associated ProteinsRNA-Binding Proteins

Identifiers

PMID25574029
PMCPMC4380077
OpenAlexW2117565279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.